Showing results (421-430 of 490) with videos related to

Sort By:
Pageof 49
Cytometry. Part B, Clinical Cytometry|March 17, 2009
A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiencyRebecca A Marsh, Joyce Villanueva, Kejian Zhang, et al.
Pediatric Blood & Cancer|April 24, 2012
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumabRebecca A Marsh, Carl E Allen, Kenneth L McClain, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 12, 2018
Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte SocietyStephan Ehl, Itziar Astigarraga, Tatiana von Bahr Greenwood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2014
Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiencyMarlene Carmo, Kimberly A Risma, Paritha Arumugam, et al.
Nanotechnology|March 31, 2017
Nanoselective area growth of defect-free thick indium-rich InGaN nanostructures on sacrificial ZnO templatesRenaud Puybaret, David J Rogers, Youssef El Gmili, et al.
Cancer Research|November 19, 2010
Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft modelPhilip J Coates, M Virginia C L Appleyard, Karen Murray, et al.
Scientific Reports|December 29, 2024
The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still's disease, and COVID-19 cytokine stormMariam Goubran, Caroline Spaner, Sophie Stukas, et al.
Diabetes, Obesity & Metabolism|October 25, 2019
Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER)Louis S Matza, Kristina S Boye, Katie D Stewart, et al.
Pageof 49